Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001091818-22-000014
Filing Date
2022-02-11
Accepted
2022-02-11 15:28:54
Documents
37
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 bfnh10k1221.htm   iXBRL 10-K 436485
2 ex311.htm EX-31.1 4968
3 ex312.htm EX-31.2 5054
4 ex321.htm EX-32.1 2243
5 ex322.htm EX-32.2 2281
11 a0101450current001.jpg GRAPHIC 21193
12 a0101450current002.jpg GRAPHIC 14139
13 a0101450current003.jpg GRAPHIC 200486
  Complete submission text file 0001091818-22-000014.txt   2170579

Data Files

Seq Description Document Type Size
6 bfnh-20211231.xsd EX-101.SCH 13655
7 bfnh-20211231_cal.xml EX-101.CAL 15080
8 bfnh-20211231_def.xml EX-101.DEF 25155
9 bfnh-20211231_lab.xml EX-101.LAB 97460
10 bfnh-20211231_pre.xml EX-101.PRE 83432
31 EXTRACTED XBRL INSTANCE DOCUMENT bfnh10k1221_htm.xml XML 75504
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

EIN.: 852138858 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51074 | Film No.: 22620150
SIC: 3826 Laboratory Analytical Instruments